Latest News

  • June 3, 2022: The first clinical study of the safety, tolerability, and efficacy of DMT in Major Depressive Disorder employs DMT synthesized by ASRI scientists.
  • December 9, 2021: ASRI raises $7.2 million in Seed financing round. Press release here.
  • April 19, 2021: The Alexander Shulgin Research Institute is incorporated by Ann Shulgin, Paul Daley, and Nicholas Cozzi. Happy Bicycle Day!